ReviewFrontiers in neuroscience2025
Cerebrovascular autoregulation in hypoxia: quantitative insights from arterial spin labeling.
Review in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Effects of Transcutaneous Vagus Nerve Stimulation on Cerebral Perfusion and Cognitive Function Under Simulated High-Altitude Hypobaric Hypoxia.Brain and behavior · 2026Trial
- Long-Term Cognitive and Functional Outcomes of Anesthesia and Surgery in Patients with Dementia.Healthcare (Basel, Switzerland) · 2026Review
- Dynamic functional connectivity variability may explain hypoxia-induced cognitive impairment at high-altitude.iScience · 2026Article
- The association between obstructive sleep apnea and total cerebral small vessel disease burden-Neurovascular insights of OSA.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypoxia, defined as an insufficient oxygen supply relative to metabolic demand, induces a cascade of cerebrovascular and metabolic responses aimed at preserving cerebral homeostasis. These responses vary depending on the temporal profile of exposure, with acute (e.g., hypoxic-ischemic encephalopathy, acute high-altitude exposure) versus chronic (e.g., obstructive sleep apnea, long-term altitude residence) conditions, and may range from compensatory vasodilation to long-term maladaptive remodeling. Arterial Spin Labeling (ASL) MRI offers a quantitative, non-invasive, and contrast-free method to assess cerebral perfusion, making it well-suited to characterize the spatial and temporal dynamics of these responses. This narrative review critically examines the application of ASL to quantify key hemodynamic parameters, including cerebral blood flow (CBF), arterial transit time (ATT), cerebrovascular reactivity (CVR), and, when integrated with complementary models, cerebral metabolic rate of oxygen consumption (CMRO₂), in the context of hypoxia. By synthesizing evidence from both environmental and pathological models induced by hypoxia, we highlight how ASL captures early signatures of cerebrovascular adaptation, impaired autoregulation, and emerging neurovascular dysfunction. Particular emphasis is placed on the potential of ASL-derived metrics to serve as early biomarkers for hypoxia-induced risk, enabling non-invasive longitudinal tracking of vascular integrity in both clinical and subclinical populations. Overall, ASL emerges as a powerful modality for elucidating the mechanisms of neurovascular adaptation to hypoxia and for supporting precision diagnostics in disorders where oxygen insufficiency constitutes a key pathophysiological driver.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.